Advertisement

Topics

Neviah Genomics Company Profile

21:57 EDT 22nd October 2018 | BioPortfolio

Neviah Genomics was jointly established in 2012 by Merck Serono, the biopharmaceutical business of Merck, and Compugen Ltd. The company operates out of the MS Ventures’ Israel Bioincubator and is focused on identifying and developing novel biomarkers for the prediction of drug-induced toxicity. MS Ventures’ Israel BioIncubator provided the initial funding for Neviah Genomics, and Compugen contributed its sophisticated proprietary computational discovery platforms to allow the development of advanced toxicogenomics diagnostic tests. It is the company’s objective that developed tests can be used for the prediction of drug-induced toxicity and integrated into a biomarker platform to support the prioritization and development of drug product candidates.


News Articles [379 Associated News Articles listed on BioPortfolio]

UCSF Names First Chief Genomics Officer

David RathsRecognizing that genomics is playing an increasingly important role in medicine, the University of California San Francisco Health has appointed its first chief genomics officer (CGO).

Microsoft Genomics Ventures into the Microbiome With Eagle Genomics

LONDON, October 15, 2018 /PRNewswire/ -- Cambridge technology innovators partner with Microsoft Genomics Microbiomic research into immune disorders and antibiotic resistance First microbiome partn...

Festival of Genomics London 2018: the landmark event making genomics mainstream

London, UK, 5th January 2018 / Sciad Newswire / This January sees the third edition of Festival of Genomics London, the largest meeting of its kind in the UK. Following two US editions of the event ...

Rosetta Genomics Ltd.: Rosetta Genomics Announces Shareholder Approval of Merger with Genoptix

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / April 26, 2018 / Rosetta Genomics Ltd. (the "Company") (NASDAQ: ROSG) today announced that its shareholders approved a proposed merger with a sub...

QUANTUM GENOMICS: Quantum Genomics receives ethics committee approval to initiate clinical study of extended-release firibastat tablets

Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat hypertension and h...

#jobs #lifescience CK Group: Genomics Manufacturing Technician – Hertfordshire

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CK Group: Genomics Manufacturing Technician – Hertfordshire . £18,000:...

10x Genomics Raises $125M toward New Product Launches, Commercial Expansion

10x Genomics said it will use a combined $125 million in new funding toward the development and launch of new products, as well as continued expansion of its commercial operations. The new funding...

Rosetta Genomics Ltd.: Nasdaq Hearing Panel Determined to Delist Shares of Rosetta Genomics from Nasdaq Stock Market Effective May 22, 2018

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / May 18, 2018 / Rosetta Genomics Ltd. (the "Company") (NASDAQ: ROSG) announced today that on May 18, 2018, it received a decision letter from NASD...

Drugs and Medications [0 Results]

None

PubMed Articles [203 Associated PubMed Articles listed on BioPortfolio]

Utilization of Genomics and Functional Genomics to Inform Clinical Decisions in IR.

Single-cell genomics.

The Global Landscape of Nursing and Genomics.

Nurses have a pivotal role in bringing the benefits of genomics and precision medicine to everyday health care, but a concerted global effort is needed to transform nursing policy and practice to addr...

Lifestyle Genomics: Addressing the Multifactorial Nature of Personalized Health.

GPU Accelerated Browser for Neuroimaging Genomics.

Neuroimaging genomics is an emerging field that provides exciting opportunities to understand the genetic basis of brain structure and function. The unprecedented scale and complexity of the imaging a...

Clinical Trials [90 Associated Clinical Trials listed on BioPortfolio]

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

This pilot clinical trial studies whether using high throughput drug sensitivity and genomics data is feasible in developing individualized treatment in patients with multiple myeloma or p...

Inflammatory Genomics in Human Carotid Artery Disease

To investigate the relationship between genetic variation in genes for inflammation and carotid artery atherosclerosis.

Companies [410 Associated Companies listed on BioPortfolio]

Neviah Genomics

Neviah Genomics was jointly established in 2012 by Merck Serono, the biopharmaceutical business of Merck, and Compugen Ltd. The company operates out of the MS Ventures’ Israe...

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

Center for Genomics and Bioinformatics

Center for Genomics and Bioinformatics The Center for Genomics and Bioinformatics (CGB) was launched in 1997 as a new academic department at the Karolinska Institute. Since then, the department has be...

Front Line Genomics

At Front Line Genomics our mission is to help deliver the benefits of genomics faster. Through our website, our magazine and the Festivals of Genomics, we support scientists, clin...

More Information about "Neviah Genomics" on BioPortfolio

We have published hundreds of Neviah Genomics news stories on BioPortfolio along with dozens of Neviah Genomics Clinical Trials and PubMed Articles about Neviah Genomics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Neviah Genomics Companies in our database. You can also find out about relevant Neviah Genomics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record